Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025)

Cabaletta Bio's (CABA) quarterly Amortizatization of Intangibles came in at $890000.0 in Q4 2025, up 11.81% year-on-year from $796000.0 in Q4 2024, and up 150.0% quarter-over-quarter from $356000.0 in Q3 2025.

Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends

Cabaletta Bio's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $890000.0 for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 11.81% year-over-year to $890000.0 in Q4 2025; TTM through Dec 2025 was $1.6 million, a 1.77% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 1.77% from the prior year.
  • Amortizatization of Intangibles rose to $890000.0 in Q4 2025 per CABA's latest filing, from $356000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $890000.0 in Q4 2025 and bottomed at -$431000.0 in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $132000.0 (2022), against an average of $202888.9.
  • Across the five-year window, Amortizatization of Intangibles tumbled 1036.96% in 2023 and jumped 4646.15% in 2024, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at -$12000.0 in 2021, then jumped by 483.33% to $46000.0 in 2022, then tumbled by 1036.96% to -$431000.0 in 2023, then jumped by 284.69% to $796000.0 in 2024, then advanced by 11.81% to $890000.0 in 2025.
  • Per Business Quant, the three latest CABA Amortizatization of Intangibles figures stand at $890000.0 (Q4 2025), $356000.0 (Q3 2025), and $142000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Cabaletta Bio 184.38 Mn 184.38 Mn - 890,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 890,000.00
Dec 31, 2025 890,000.00
Sep 30, 2025 356,000.00
Sep 30, 2025 356,000.00
Jun 30, 2025 142,000.00
Jun 30, 2025 142,000.00
Mar 31, 2025 167,000.00
Mar 31, 2025 167,000.00
Dec 31, 2024 796,000.00
Dec 31, 2024 796,000.00
Sep 30, 2024 339,000.00
Sep 30, 2024 339,000.00
Jun 30, 2024 -224,000.00
Jun 30, 2024 -224,000.00
Mar 31, 2024 617,000.00
Mar 31, 2024 617,000.00
Dec 31, 2023 -431,000.00
Dec 31, 2023 -431,000.00
Sep 30, 2023 653,000.00
Sep 30, 2023 653,000.00